Amend the bill in section 1 in §1711-E in subsection 4 in paragraph D in the first line (page 2, line 35 in L.D.) by inserting after the following: " individual" the following: ' or the individual's health care provider'

Amend the bill in section 1 in §1711-E in subsection 4 in paragraph E in the first line (page 2, line 39 in L.D.) by striking out the following: " Transfers" and inserting the following: ' The transfer or use of prescription drug information'

Amend the bill in section 1 in §1711-E in subsection 4 in paragraph E in the last line (page 2, line 41 in L.D.) by striking out the following: " ; and" and inserting the following: ' ;'

Amend the bill in section 1 in §1711-E in subsection 4 in paragraph F in the last line (page 3, line 2 in L.D.) by striking out the following: " prescriber." and inserting the following: ' prescriber; and'

Amend the bill in section 1 in §1711-E in subsection 4 by inserting after paragraph F the following:

summary

This amendment is the minority report of the committee. The amendment clarifies that prescriber information may be used for the following:

1. Care management communications to an individual's health care provider;

2. Pharmacy reimbursement, prior authorization and formulary compliance, patient care management, utilization review, health care research and transfers required by law; and

3. Noncommercial purposes for which disclosure is allowed under the Maine Revised Statutes, Title 22, section 1711-C, subsection 6, paragraph B, paragraphs D to M and paragraph P.